|
1
|
Kalupahana NS, Moustaid-Moussa N and
Claycombe KJ: Immunity as a link between obesity and insulin
resistance. Mol Aspects Med. 33:26–34. 2012. View Article : Google Scholar
|
|
2
|
Liang CP, Han S, Senokuchi T and Tall AR:
The macrophage at the crossroads of insulin resistance and
atherosclerosis. Circ Res. 100:1546–1555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reaven G: All obese individuals are not
created equal: insulin resistance is the major determinant of
cardiovascular disease in overweight/obese individuals. Diabetes
Vasc Dis Res. 2:105–112. 2005. View Article : Google Scholar
|
|
4
|
Fukui Y and Motojima K: Expression of
resistin in the adipose tissue is modulated by various factors
including peroxisome proliferator-activated receptor alpha.
Diabetes Obes Metab. 4:342–345. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guilherme A, Virbasius JV, Puri V and
Czech MP: Adipocyte dysfunctions linking obesity to insulin
resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 9:367–377.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu H, Barnes GT, Yang Q, et al: Chronic
inflammation in fat plays a crucial role in the development of
obesity-related insulin resistance. J Clin Invest. 112:1821–1830.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dandona P, Aljada A and Bandyopadhyay A:
Inflammation: the link between insulin resistance, obesity and
diabetes. Trends Immunol. 25:4–7. 2004. View Article : Google Scholar
|
|
8
|
Shoelson SE, Herrero L and Naaz A:
Obesity, inflammation, and insulin resistance. Gastroenterology.
132:2169–2180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weisberg SP, Mccann D, Desai M, et al:
Obesity is associated with macrophage accumulation in adipose
tissue. J Clin Invest. 112:1796–1808. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Greenberg A and Mcdaniel M: Identifying
the links between obesity, insulin resistance and beta-cell
function: potential role of adipocyte-derived cytokines in the
pathogenesis of type 2 diabetes. Eur J Clin Invest. 32(Suppl 3):
24–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hirosumi J, Tuncman G, Chang L, et al: A
central role for JNK in obesity and insulin resistance. Nature.
420:333–336. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hardy OT, Perugini RA, Nicoloro SM, et al:
Body mass index-independent inflammation in omental adipose tissue
associated with insulin resistance in morbid obesity. Surg Obes
Relat Dis. 7:60–67. 2011. View Article : Google Scholar
|
|
13
|
Troyanskaya O, Cantor M, Sherlock G, et
al: Missing value estimation methods for DNA microarrays.
Bioinformatics. 17:520–525. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fujita A, Sato J, Rodrigues L, Ferreira C
and Sogayar M: Evaluating different methods of microarray data
normalization. BMC Bioinformatics. 7:4692006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smyth GK: Limma: linear models for
microarray data. Bioinformatics and Computational Biology Solutions
using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry
R and Huber W: Springer; New York: pp. 397–420. 2005, View Article : Google Scholar
|
|
16
|
Dudoit S, Shaffer JP and Boldrick JC:
Multiple hypothesis testing in microarray experiments. Stat Sci.
18:71–103. 2003. View Article : Google Scholar
|
|
17
|
Breitkreutz BJ, Stark C and Tyers M:
Osprey: a network visualization system. Genome Biol. 4:R222003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Willis RC and Hogue CW: Searching,
viewing, and visualizing data in the Biomolecular Interaction
Network Database (BIND). Curr Protoc Bioinformatics. 8:8.92006.
|
|
19
|
Breitkreutz B-J, Stark C and Tyers M: The
GRID: the general repository for interaction datasets. Genome Biol.
4:R232003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Kirov S and Snoddy J: WebGestalt:
an integrated system for exploring gene sets in various biological
contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duncan D, Prodduturi N and Zhang B:
WebGestalt2: an updated and expanded version of the Web-based Gene
Set Analysis Toolkit. BMC Bioinformatics. 11(Suppl 4): P102010.
View Article : Google Scholar
|
|
22
|
Kanehisa M, Goto S, Sato Y, et al: KEGG
for integration and interpretation of large-scale molecular data
sets. Nucleic Acids Res. 40:D109–D114. 2012. View Article : Google Scholar :
|
|
23
|
Shoelson SE and Goldfine AB: Getting away
from glucose: fanning the flames of obesity-induced inflammation.
Nat Med. 15:373–374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang YL, Guh JY, Yang ML, et al:
Interaction between high glucose and TGF-beta in cell cycle protein
regulations in MDCK cells. J Am Soc Nephrol. 9:182–193.
1998.PubMed/NCBI
|
|
25
|
Yang L, Roh YS, Song J, et al:
Transforming growth factor beta signaling in hepatocytes
participates in steatohepatitis through regulation of cell death
and lipid metabolism. Hepatology. 59:483–495. 2013. View Article : Google Scholar
|
|
26
|
Wong J, Kim P, Peacock J, et al: Pten
(phosphatase and tensin homologue gene) haploinsufficiency promotes
insulin hypersensitivity. Diabetologia. 50:395–403. 2007.
View Article : Google Scholar :
|
|
27
|
Lo YT, Tsao CJ, Liu IM, Liou SS and Cheng
JT: Increase of PTEN gene expression in insulin resistance. Horm
Metab Res. 36:662–666. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Butler M, Mckay RA, Popoff IJ, et al:
Specific inhibition of PTEN expression reverses hyperglycemia in
diabetic mice. Diabetes. 51:1028–1034. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakashima N, Sharma PM, Imamura T,
Bookstein R and Olefsky JM: The tumor suppressor PTEN negatively
regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem.
275:12889–12895. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang X, Powelka AM, Soriano NA, Czech MP
and Guilherme A: PTEN, but not SHIP2, suppresses insulin signaling
through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1
adipocytes. J Biol Chem. 280:22523–22529. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lebrun P, Baron V, Hauck CR, Schlaepfer DD
and Van Obberghen E: Cell adhesion and focal adhesion kinase
regulate insulin receptor substrate-1 expression. J Biol Chem.
275:38371–38377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baron V, Calléja V, Ferrari P, et al:
p125Fak focal adhesion kinase is a substrate for the insulin and
insulin-like growth factor-I tyrosine kinase receptors. J Biol
Chem. 273:7162–7168. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bisht B, Goel H and Dey C: Focal adhesion
kinase regulates insulin resistance in skeletal muscle.
Diabetologia. 50:1058–1069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Le Stunff C, Dechartres A, Mariot V, et
al: Association analysis indicates that a variant GATA-binding site
in the PIK3CB promoter is a Cis-acting expression quantitative
trait locus for this gene and attenuates insulin resistance in
obese children. Diabetes. 57:494–502. 2008. View Article : Google Scholar
|
|
35
|
Clément K, Stunff CL, Meirhaeghe A, et al:
In obese and non-obese adults, the cis-regulatory rs361072 promoter
variant of PIK3CB is associated with insulin resistance not with
type 2 diabetes. Mol Genet Metab. 96:129–132. 2009. View Article : Google Scholar
|
